Connection

Bassam Hallis to Equivalence Trials as Topic

Back to Details
This is a "connection" page, showing publications Bassam Hallis has written about Equivalence Trials as Topic.
Bassam Hallis
Connection Strength
0.054
Equivalence Trials as Topic
  1. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021 09 04; 398(10303):856-869.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.